Member Info for MrIndia

Pingu ... A lovely post and even though i don't understand level 2, your representation of the alias on here is spot on so made me laugh.

Indeed investing in junior pharma is painful and requires a lot of trust in the information that the company puts out. The share price is highly volatile and in periods of no news, is normally battered and driven down by traders. I have seen this with all other pharma as well. Then when u don't expect it, boom !!!! and u get a 1300% rise like the therapeutic company in the USA.

This board is now just waiting. Some are topping up, majority of LTHs are just in wait mode. I have more confident than before based on what Haywain said. If his scientific view is correct, an RNS could drop anytime stating that the info has been sent to FDA triggering the max 30 day response. If Vlad does his job right, we will then get approval and become clinical before xmas to the trials can be started. That will be the inflection point for hemo and that's what we all wait for.

Pingu ... nice to hear ... Let's hope these people are in the know and news is coming this week. Every day closer to the big rerate ...

Actually Vlad and hemo owe us all payments for stress but I will be happy to take it in share rerate. LOLs

06-Nov-23 08:24:58 2.084 750,000 Unknown* 2.00 2.10 15.63k O

06-Nov-23 08:17:27 2.059 750,000 Unknown* 2.00 2.10 15.44k O

Haywain ... Thanks for the clarification. This makes me more positive than before. The traders window to trade and the chance to procure at a low price seems to be shortening. Looking forward to an RNS and the rerate finally starting !!!!

Well i wouldnt listen to your dribble of daily complaining ... mr whiner himself. I trust people like Haywain who is a scientist and tells the truth and appreciate him providing his feedback ... in the abscence of anything from HEMO themselves !!!!

HT ... can I ask what RNS you are expecting since based on haywain's analysis there is no guarantee CH being lifted will happen in 2023?

Sorry last question. The photo that Vlad posted stating he wishes it to be negative, could that be the new lentivurus and he is about to resubmit the results so the 30 day clock is started?

Wow that is very clear now and thank you so much. I have learnt a lot. Its now just a wait game and hope that what they submitted is satisfactory and the CH is lifted soon. Trading this stock seems to be getting more risky and I am happy to wait for an update now you have educated me. It would be a nice xmas present to get approval in 2023.

Any information you can provide based on your knowledge is useful for us to judge the value of this investment since hemo updates us very infrequently and these quiet periods are fun for the traders who live on FUD

Haywain ... Sadly the share price is where it is because of people like One2one so i agree with JHFH that its futile discussing anything with him. He wants to nit pick at anything negative so he can drive the price down. Stu his chatbot brother did the same before but he seems to have gone quiet and must have bought in already and is waiting for the rise

One genuine question ... when the RNS came out stating the FDA had given the nod for CH to be lifted based on a number of things being done, can you eloborate from your experience what physically HEMO would need to do to get this approval official? I ask because I am confused and no one has given an accurate answer in that what does hemo exactly need to produce / do / exhibit to the FDA and then will they generally take 30 days to approve or not.

Sorry for the silly question but i think this confusion has created a perfect opportunity for traders to trade on this stock and add to the frustration to many shareholders.

Hi Haywain

Many thanks for your feedback. I think many on here are expecting approval and clinical well before end year and hopefully November but appreciate your analysis as well. I would have thought though when vlad stated in the RNS that he expects trials to start in 2023, that implied he expects approval to be done by now. Let's hope he doesnt over commit on dates in his excitement like he has done many times before

For me it doesnt matter as long as it finally gets the approval and we can move on with trials and bigger news on CBR and CDX, !!!

Hi Haywain ... Since you are the scientist and very knowledgeable what would your expectation be of IND approval timelines based on the FDA approval already? Would you know if they have to do the tests again or will something else suffice?

It does seem like news is due very very soon but it would be great to get a scientists view and not the chatbot?

Even 121 now has confirmed that clinical approval will come. We have seen this share traded between 1.95 and 2.4 and most likely it will move between there until news drops. Whether its Monday or next month, we know going clinical for a company is a major rerate. Nothing is factored into this price. Once its goes clinical and gets over $50 mcap it will attract institutions and bigger pharma and then traders will become irrelevant and we could see bigger movements with bigger volumes daily.

DYOR but try to find a share that could rerate from 2p to any variation of 2p (2p - 10p) in the next 60 days. Pretty good returns if you are averaging down or investing for the 1st time.

Its a been long wait since this was nearly 4.8p in January and even 10p+ a few years ago. Whether that was on hype of Covid or CBR, it shows what can happen when people get behind a share.

Years on, we have a solid partner called prevail who invested at 6p. We have provisional IND approval from the FDA and have CBR going through In vitro / in vivo tests. so why is this share sitting sadly at 2p ... I strongly believe it comes down to the type of investors that hemo attracts (mainly people with short time span and a goal of 10% profit) and nearly all retail who flit between stocks when they see a rise or eject when there is a little conjecture.

People have stated prices as high as 20p, rerate to $300 MCAP or a few 100% rise. Its all irrelevant if you havent invested at the low price (which it is now) and then just sit back and watch the fireworks when they happen. We are in the month of news ... and I know many have been saying that for months now but do your own calculations that if they expect to start trials in 2023, they must get approval very soon to hit that deadline. Prevail would have invested knowing that and feeling comfortable it can be done and they have seniors from the FDA in their organisation !!!!

Yes its frustrating waiting and seeing share price red most days but we are close and many who have been here for years will hopefully be celebrating in a few weeks and have a nice Xmas. GLA

Hi Dhub, sorry I didnt reply to your post as was busy with other items. I am also trying to stay away from the board since it is toxic and people are here to only attack others rather than give their opinions and views on the status of hemo.

I haven't sold. I am here till IND Trials start and CBR news lands. There is no way I am going to walk away from becoming a millionaire. This is the biggest gamble of my life and whether I like the CEO is irrelevant. I believe in the science, prevail and the FDA and most importantly myself. I am still confident that we will wake up one morning and get the news we all want and then the scramble for cheap shares will start and I don't want to be in that battle !!

Mickey

The RNS confirming the FDA had approved the plan for lifiting IND was 18th Sept. That is 6 weeks ago. I would expect that Hemo would have done some provisional tests 1st before submitting their plan. If we assume time to carry out the tests with the new lentivirus and even 3 of them at 2 weeks each, we must be now in that period of getting validation from the FDA.

Haywain is the scientist on here and probably is best to give his view on when IND will be approved but I feel everyone is now just in wait mode. Most impatient sellers have sold out and people who want to build a position or average down will do it now. We can keep predicting when news will land but that is futile with hemo unless you work for the company or are VLAD. We just to hope that he will finally deliver the goods after promising us with hope for the last 4 years !!!

JHFH ... No one is attacking vlad because of the video. It's because it was on his personal twitter and if HEMO should have been on the hemo site. Also, it created more confusion than helping as can be seen from the share price today

As a normal human being, if he wants to update the shareholders, why doesn't he create an official update and post it on hemo website or use a real marketing company or at the very least explain what it is for and how it benefits hemo !!!

It's about transparency ... you have been critical of vlad in the past for this type of behaviour and he continues to do it ... at the expense of the share price !!!

Actually it was my decision ... she had an affair simonthezealot and i caught them in the act .. very sad situation

MrsIndia ... you are either dillusional or a very sad individual to troll Mr India. We got divorced 10 years ago so please go and find another suitable victim.

Moorscloud ... You maybe dont follow up vlad's past ...

- He is posting from his personal twitter so should have no relevance to hemo.

- Whenever he tweets a video or something he does it to pump or create hype but it never does. I personally think he does it to deflect from something. I have seen that in the past 3 years

- He never explains what these tweets are. He did this with the CBR video and then never gave an update on bait and let people assume again

As the CEO of a company he should work through official RNS channels since these tweets and videos have a detrimental affect on a share price that is already struggling to keep above 2p. We have seen this before ... this type of video just allows the trolls to create a negative narrative

All everyone wants on here is IND and the company to move on and become a clinical one. We have blocked money for 4 years in this game and for once, vlad needs to step up and support his investors and get something right